A detailed history of Pnc Financial Services Group, Inc. transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 100 shares of IDNA stock, worth $2,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$2,300
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$20.35 - $24.44 $12,250 - $14,712
-602 Reduced 85.75%
100 $2,000
Q1 2023

May 15, 2023

SELL
$22.48 - $27.9 $3,484 - $4,324
-155 Reduced 18.09%
702 $16,000
Q2 2022

Aug 12, 2022

SELL
$25.09 - $35.91 $20,072 - $28,727
-800 Reduced 48.28%
857 $24,000
Q1 2022

May 12, 2022

BUY
$31.36 - $43.88 $13,390 - $18,736
427 Added 34.72%
1,657 $57,000
Q3 2021

Nov 05, 2021

BUY
$48.15 - $55.47 $26,482 - $30,508
550 Added 80.88%
1,230 $62,000
Q2 2021

Aug 06, 2021

BUY
$43.63 - $52.03 $8,289 - $9,885
190 Added 38.78%
680 $35,000
Q1 2021

May 07, 2021

BUY
$42.64 - $54.83 $20,893 - $26,866
490 New
490 $22,000

Others Institutions Holding IDNA

About ISHARES TR GENOMICS IMMUNOLOGY


  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.